ORD_16795/2024

Prozessuale & UnteranträgeVersäumnisurteileCourt of AppealDecision By Default—

Übersicht Entscheidungen Zitate Dokumente Zeitverlauf

Parteien

Kläger

Abbott Laboratories(Abbott Group)
Abbott Diabetes Care Inc.(Abbott Group)
Abbott France(Abbott Group)
Abbott (S.V./N.V.)(Abbott Group)
Abbott B.V.(Abbott Group)
Abbott s.r.l.(Abbott Group)
Abbott Scandinavia Aktiebolag(Abbott Group)
Abbott GmbH(Abbott Group)
Abbott Diagnostics GmbH(Abbott Group)
Abbott Logistics B.V.(Abbott Group)

Vertreter: Christian Dekoninck; Patricia Cappuyns; François Pochart; Wim Maas; Dietrich Kamlah

Beklagte

Dexcom Inc.(Dexcom Group)

Vertreter: Anne-Charlotte le Bihan; Laurent Labatte

Richter

Klaus GrabinskiPresident of the Court of Appeal

Patente

Ausgang

Abgewiesen

Eingereicht: —

Erste Entscheidung: 14. März 2024

Sprache: —

The President of the Court of Appeal declared the Abbott entities' appeal inadmissible from the outset because it was brought without leave to appeal as required under Rule 220.2 RoP, and noted that an inadmissible appeal cannot be withdrawn.